Skip to content
2000
Volume 21, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603
side by side viewer icon HTML

Abstract

Background

Cytomegalovirus (CMV) infection is common in the digestive and central nervous systems and can infect the entire digestive tract from the mouth to the rectum. In immunocompromised patients, CMV infection is prone to develop into CMV disease, especially in Acquired Immune Deficiency Syndrome (AIDS) patients. Severe cases may accelerate the progression of AIDS patients and form systemic CMV infection. Timely diagnosis and treatment are very important for the prognosis of patients.

Case Presentation

In this paper, we report a 36-year-old man with a Human Immunodeficiency Virus (HIV) infection complicated with CMV colitis. Three weeks ago, he developed abdominal pain with fresh blood in the stool, accompanied by anal pain. He was found to be HIV positive 8 years ago. An enhanced CT scan showed edema and irregular thickening of the rectal wall, obvious enhancement of the mucosa, and multiple enlarged lymph nodes around. 18F-FDG PET/CT imaging displayed diffuse rectum wall thickening and increased glucose metabolism, and the SUV max was 12.7. There were multiple enlarged lymph nodes around the rectum, glucose metabolism was increased, and the SUVmax was 4.6.

Conclusion

18F-FDG-PET imaging technology has potential value in the diagnosis of CMV colitis, especially in immunocompromised patients. Detection of FDG concentrations in the colon wall can help diagnose CMV infection and understand the extent of the lesion, which is essential for the timely initiation of antiviral therapy.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056361753241226065721
2025-01-01
2025-05-11
The full text of this item is not currently available.

References

  1. FulkersonH.L. NogalskiM.T. Collins-McMillenD. YurochkoA.D. Overview of human cytomegalovirus pathogenesis.Methods Mol. Biol.2021224411810.1007/978‑1‑0716‑1111‑1_133555579
    [Google Scholar]
  2. Yerushalmy-FelerA. PadlipskyJ. CohenS. Diagnosis and management of CMV colitis.Curr. Infect. Dis. Rep.2019212510.1007/s11908‑019‑0664‑y30771028
    [Google Scholar]
  3. DieterichD.T. RahminM. Cytomegalovirus colitis in AIDS: Presentation in 44 patients and a review of the literature.J. Acquir. Immune Defic. Syndr.199144Suppl. 1S29S351848619
    [Google Scholar]
  4. SattwikaP.D. SubrontoY.W. RetnowulanH. SattwikaK.A. NurdiatiD.S. Anti-cytomegalovirus preemptive therapy to prevent cytomegalovirus disease in HIV-infected patients: A systematic review.Infect. Dis. (Lond.)202355322123310.1080/23744235.2023.216570836630310
    [Google Scholar]
  5. MattioniS. PavieJ. PorcherR. ScieuxC. DenisB. De CastroN. SimonF. MolinaJ.M. Assessment of the efficacy and safety of pre-emptive anti-cytomegalovirus (CMV) therapy in HIV-infected patients with CMV viraemia.Int. J. STD AIDS201526530631210.1177/095646241453614624845948
    [Google Scholar]
  6. SkipperC.P. SchleissM.R. Cytomegalovirus viremia and advanced HIV disease: Is there an argument for anti-CMV treatment?Expert Rev. Anti Infect. Ther.202321322723310.1080/14787210.2023.217240036691835
    [Google Scholar]
  7. JohnsonJ. AffolterK. BoyntonK. ChenX. ValentineJ. PetersonK. CMV disease in IBD: Comparison of diagnostic tests and correlation with disease outcome.Inflamm. Bowel Dis.20182471539154610.1093/ibd/izy04529718356
    [Google Scholar]
  8. BaniakN. KanthanR. Cytomegalovirus colitis: An uncommon mimicker of common colitides.Arch. Pathol. Lab. Med.2016140885485810.5858/arpa.2015‑0176‑RS27472242
    [Google Scholar]
  9. GoodmanA.L. MurrayC.D. WatkinsJ. GriffithsP.D. WebsterD.P. CMV in the gut: A critical review of CMV detection in the immunocompetent host with colitis.Eur. J. Clin. Microbiol. Infect. Dis.2015341131810.1007/s10096‑014‑2212‑x25097085
    [Google Scholar]
  10. ShiehA.C. GulerE. TirumaniS.H. DumotJ. RamaiyaN.H. Clinical, imaging, endoscopic findings, and management of patients with CMV colitis: A single-institute experience.Emerg. Radiol.202027327728410.1007/s10140‑020‑01750‑z31955314
    [Google Scholar]
  11. AlacamS. KarabulutN. BakirA. OnelM. BuyukM. GulluogluM. AgacfidanA. Diagnostic significance of cytomegalovirus DNA quantitation in gastrointestinal biopsies: Comparison with histopathological data and blood cytomegalovirus DNA.Eur. J. Gastroenterol. Hepatol.2021331404510.1097/MEG.000000000000184032658013
    [Google Scholar]
  12. JenaA. MishraS. SinghA.K. SekarA. SharmaV. Cytomegalovirus in ulcerative colitis: An evidence-based approach to diagnosis and treatment.Expert Rev. Gastroenterol. Hepatol.202216210912010.1080/17474124.2022.203266235057693
    [Google Scholar]
  13. NihashiT. ProK. KatoT. KatoR. OkudaM. ArimaT. BundoM. KawatsuS. HayasakaK. IshigakiT. An abnormal accumulation of fluorine-18-FDG PET in cytomegalovirus enteritis—A case report.Ann. Nucl. Med.2006201757810.1007/BF0298559516485579
    [Google Scholar]
  14. KjaerA. RibberholtI. ThomsenK. IbsenP. MarkovaE. GraffJ. (18)f-FDG PET/CT findings in cytomegalovirus colitis.Diagnostics (Basel)201891310.3390/diagnostics901000330587768
    [Google Scholar]
  15. KouijzerI.J.E. Mulders-MandersC.M. Bleeker-RoversC.P. OyenW.J.G. Fever of unknown origin: The value of FDG-PET/CT.Semin. Nucl. Med.201848210010710.1053/j.semnuclmed.2017.11.00429452615
    [Google Scholar]
  16. BuchritsS. McNeilR. AvniT. FredmanD. GuzD. Gafter-GviliA. The contribution of 18f FDG PET-CT for the investigation of fever of unknown origin and inflammation of unknown origin.Am. J. Med.2024137762963910.1016/j.amjmed.2024.03.01738499136
    [Google Scholar]
  17. KhanA.A. MahendranR.K. PerumalK. FaheemM. Dual-3DM(3)AD: mixed transformer based semantic segmentation and triplet pre-processing for early multi-class Alzheimer’s diagnosis.IEEE Trans. Neural Syst. Rehabil. Eng.20243269670710.1109/TNSRE.2024.335772338261494
    [Google Scholar]
  18. AlqarafiA. Ahmad KhanA. Kumar MahendranR. Al-SaremM. AlbalwyF. Multi-scale GC-T2: Automated region of interest assisted skin cancer detection using multi-scale graph convolution and tri-movement based attention mechanism.Biomed. Signal Process. Control20249510631310.1016/j.bspc.2024.106313
    [Google Scholar]
  19. ZubairM. Md RaisH.B. UllahF. Al-TashiQ. FaheemM. Ahmad KhanA. Enabling predication of the deep learning algorithms for low-dose CT scan image denoising models: A systematic literature review.IEEE Access202412790257905010.1109/ACCESS.2024.3407774
    [Google Scholar]
  20. KhanA.A. MadendranR.K. ThirunavukkarasuU. FaheemM. D 2 PAM : Epileptic seizures prediction using adversarial deep dual patch attention mechanism.CAAI Trans. Intell. Technol.20238375576910.1049/cit2.12261
    [Google Scholar]
  21. Shiyam SundarL.K. GutschmayerS. MaenleM. BeyerT. Extracting value from total-body PET/CT image data - the emerging role of artificial intelligence.Cancer Imaging20242415110.1186/s40644‑024‑00684‑w38605408
    [Google Scholar]
/content/journals/cmir/10.2174/0115734056361753241226065721
Loading
/content/journals/cmir/10.2174/0115734056361753241226065721
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test